Senior insider sale
Chief Medical Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$266.4K
10.87K shares
What this filing means
SCHOENBERG MARK plans to sell 10.87K shares of UROGEN PHARMA LTD. valued at approximately $266.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/19/2025ACC: 0001000275-25-000163
Officer· Chief Medical Officer
Since Jan 2019
10.87K
Shares to sell
$266.4K
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
N/A
1/27/2023
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/27/2023 | STOCK OPTION EXERCISE N/A | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
871.00
Market value
$16.4K
9/8/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$250.0K
11/19/2025
Total
Units
10.87K
Value
$266.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/8/2025 | 871.00 | $16.4K | — | Completed |
| Planned — Approximate Date | ||||
11/19/2025 | 10K | $250.0K | NASDAQ | Planned |
| Total | 10.87K | $266.4K | ||